Monograph Details
|
|
Ob/Gyn
> Vaginal infections
|
|
FEMSTAT 3 |
| Manufacturer |
|
Bayer Corp, Consumer Care Div. |
| Legal Classification |
|
OTC |
| Pharmacological Class |
|
Azole antifungal. |
| Generic Name |
|
Butoconazole nitrate 2%; vaginal crm. |
| Indications |
|
Vulvovaginal candidiasis. |
| Children |
|
Not recommended. |
| Adults |
|
1 applicatorful intravaginally at bedtime for 3 consecutive nights; may repeat. |
| Precautions |
|
Concomitant use of contraceptive diaphragm, condoms, or tampons: not recommended. Confirm diagnosis by KOH smears and/or cultures. If treatment ineffective, reconfirm diagnosis. Discontinue if sensitization occurs. Pregnancy. Nursing mothers. |
| Adverse Reactions |
|
Vulvovaginal burning, vulvar itch, discharge, soreness, swelling. |
| How Supplied |
Crm—20g (w. 3 disposable applicators)
Prefilled applicator (5g)—3 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
